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Tobacco plants transformed with a cDNA copy of RNA 1 of the Fny strain of cucumber mosaic virus (CMV) promoted the
asymptomatic accumulation of inoculated viral RNAs 2 and 3, which could be detected in noninoculated leaves, suggesting
that the transgene also permitted viral long-distance movement. Typical symptoms of infection appeared later and correlated
with the appearance of viral RNA 1 regenerated from the transgenic mRNA. Although all R0-generation plants were
susceptible to Fny-CMV, one line displaying variable susceptibility to the virus in R1-and R2-generations led to selected
R3-generation lines with systemic resistance to Fny-CMV. In the inoculated leaves of resistant plants, a dramatic decrease
in the accumulation of viral RNA 1 was observed, relative to susceptible plants. No viral RNAs were detected in noninoculated
leaves of the resistant plants, but such leaves were susceptible to infection. Furthermore, these leaves could sustain
replication of inoculated CMV RNAs 2 and 3, indicating that a complete transgene-silencing had not been induced. Although
a transgene-mediated, CMV RNA 1-suppression occurred in the inoculated leaf of resistant plants, the absence of a complete
systemically acquired silencing suggests the existence of additional interferences with viral infection that prevented systemic
infection by viral RNAs 2 and 3. © 1998 Academic Press
INTRODUCTION
Cucumber mosaic virus (CMV), a virus species within the
family Bromoviridae, is a tripartite plant RNA virus with four
major encapsidated RNAs (Palukaitis et al., 1992). RNAs 1
and 2 encode viral components of the viral replicase: the 1a
protein, a putative helicase, and the 2a protein, the viral
polymerase (Hayes and Buck, 1990). In addition to these
roles in replication, RNA 1 has a function in virus movement
(Gal-On et al., 1994), whereas RNA 2 also encodes a small
protein of 13 kDa (2b), which may facilitate long-distance
movement of the virus in certain hosts (Ding et al., 1995).
RNA 3 encodes the viral movement (3a) and coat (CP)
proteins. The latter is expressed via subgenomic RNA 4.
Both the 3a protein and the CP are required for virus
cell-to-cell movement (Suzuki et al., 1991; Boccard and
Baulcombe, 1993; Canto et al., 1997).
Transgenic expression of biologically active 1a or 2a
proteins, capable of sustaining replication of the heter-
ologous viral RNAs (1 or 2, plus 3) in planta, has been
reported for three members of Bromoviridae: alfalfa mo-
saic virus (AlMV; van Dun et al., 1988), brome mosaic
virus (BMV; Mori et al., 1992), and CMV (Suzuki et al.,
1996). Furthermore, when both proteins were simulta-
neously expressed in the same plant from transgenes
encoding full-length viral RNAs, a viral replicon was
generated (Mori et al., 1992; Suzuki et al., 1996).
No resistance has been reported so far in plants
expressing either biologically active 1a or 2a proteins
alone for any member within the Bromoviridae. However,
resistance has been found in some transgenic plants
that simultaneously express both proteins and seems to
be related to the generation of a viral replicon. For ex-
ample, transgenic tobacco plants expressing a BMV rep-
licon showed a drastic suppression in the levels of ac-
cumulation of viral RNA in protoplasts (Kaido et al., 1995).
In contrast, little inhibition of replication was observed in
protoplasts from plants expressing both BMV 1a and 2a
proteins from transgenes lacking the 39 end noncoding
regions (NCRs) of the viral RNAs and thus unable to
reconstitute a viral replicon (Kaido et al., 1995). No resis-
tance to viral infection was reported in plants expressing
both biologically active 1a and 2a proteins of AlMV,
which were also unable to reconstitute a viral replicon,
due to deletions in the viral NCRs at the 59 and 39 ends
(Taschner et al., 1991). By contrast, some resistance was
described in transgenic tobacco expressing a CMV rep-
licon, although it was sensitive to the nature of the
inoculum and effective only at very low doses of virus
(Suzuki et al., 1996). As in the BMV replicon-transgenic
plants (Kaido et al., 1995), the resistance to CMV also
involved suppression of the replication of the homolo-
gous virus in protoplasts.
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Resistance also has been described in plants ex-
pressing defective forms of the viral replicase. Strong
resistance was found in tobacco plants expressing a
defective form of the CMV 2a protein (Anderson et al.,
1992). In those plants, a marked reduction in the rate of
virus replication in the inoculated cells was observed,
but there also was evidence of a second interference
with the systemic movement of the virus (Carr et al., 1994;
Hellwald and Palukaitis, 1995; Wintermantel et al., 1997).
The resistance was independent of the nature and dose
of the inoculum but was effective only against the CMV
strain from which the transgene originated and other
closely related strains of CMV subgroup I but not strains
of CMV subgroup II (Anderson et al., 1992; Zaitlin et al.,
1994). Resistance was targeted to CMV RNA 2 (Hellwald
and Palukaitis, 1995). Several transgenes expressing de-
fective forms of the 2a protein of AlMV induced less
extreme protection against the virus. In those plants,
resistance correlated with high levels of transgene ex-
pression (Brederode et al., 1995). It was suggested that
the nonfunctional 2a protein encoded by the transgene
could itself play a role in the resistance mechanism
(Brederode et al., 1995).
Transgenic tobacco expressing CMV RNA 1 did not
show resistance to CMV but was able to complement
infection of CMV RNAs 2 and 3 by the generation of
biologically active CMV RNA 1 (Suzuki et al., 1996). How-
ever, because the 1a protein of the Fny strain of CMV
was not detectable in CMV-infected protoplasts, in con-
trast to the 2a, 3a, or CPs (A. Gal-On, C. H. Kim and
P. Palukaitis, unpublished data), it appeared that very
little 1a protein was required to support CMV replication.
This made it likely that tobacco plants transgenic for
Fny-CMV RNA 1, expressing low levels of biologically
active 1a protein, would support replication of RNA 1-de-
fective virus by complementation of viral RNAs 2 and 3.
Moreover, based on the previous transgene-expression
studies described above, CMV RNA 1-expressing trans-
genic tobacco that showed complementation of CMV
replication would not be expected to show resistance to
CMV, whereas transgenic plants that did show resis-
tance to CMV, due to transgene silencing, would not be
expected to show complementation. However, as shown
here, contrary to expectations, transgenic tobacco ex-
pressing CMV RNA 1 could exhibit both resistance to
CMV infection and complementation of CMV replication.
RESULTS
The 1a protein expressed from the transgene
complements replication of CMV RNAs 2 and 3 in
R0-generation plants
Tobacco plants were transformed using a construct
encoding a full-length RNA 1 of Fny-CMV, modified by the
addition of sequences encoding six histidines at the 39
end of the 1a gene. In addition, the construct contained
nonviral sequences at both 39 and 59 termini (Fig. 1). Two
calli were obtained: callus A, from which plant lines A1,
A2, and A3 were regenerated, and callus B, from which
plant lines B1, B2, B3, B4, and B5 were regenerated.
The transgene could be detected by polymerase chain
reaction (PCR) in all R0-generation plants except A3 (not
shown). Attempts to clearly detect the transgenic 1a
protein in these plants by Western blotting were unsuc-
cessful (not shown). Therefore, a complementation test
was used to demonstrate transcription of the transgene
into mRNA and translation into biologically active 1a
protein by inoculation of the R0-generation plants with
Fny-CMV transcript RNAs 2 and 3. Replication of these
RNAs was detected by reverse transcription PCR (RT-
PCR) of viral sequences corresponding to RNAs 2 and 3
and/or Northern blot hybridization analysis of total RNA
extracted from inoculated and noninoculated upper
asymptomatic leaves. CMV RNAs were detected in all
plants except plant A3 (Fig. 2, lanes 1 and 2 vs lanes 3
and 4; data not shown). Thus, the transgenic 1a protein
complemented the RNA 1-deficient virus for replication.
However, the levels of viral RNA detected by Northern
blot hybridization analysis were considerably lower than
the levels of viral RNAs detected in tissue inoculated
with all three CMV RNA transcripts (Fig. 2, lanes 1 and 2
vs lane 6). Moreover, RNA 1 was not detected in the
transgenic plants by the probe, which is specific to the 39
terminal sequences common to each CMV RNA (Fig. 2,
lanes 1 and 2).
Viral RNA 1 regenerates from the transgenic mRNA
Between 12 and 20 days postinoculation (d.p.i.), symp-
toms began to appear in the newly emerging leaves of
R0-generation plants showing complementation and rep-
lication of viral RNAs 2 and 3 (Fig. 3). Some foci of
infection showed very mild symptoms visible only under
transmitted light (Figs. 3B vs 3A, arrows). These symp-
FIG. 1. Schematic representation of the expression construct used
for the transformation of tobacco plants. A PCR fragment obtained from
the RNA 1 full-length cDNA clone, pFny109 C-His, was inserted into the
expression vector pROK2. NPTII, 35S, T7, and NOS Ter refer to neomy-
cin phosphotransferase II, cauliflower mosaic virus 35S RNA promoter,
T7 RNA promoter, and nopaline synthase gene transcriptional termi-
nator, respectively.
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toms increased gradually in severity (Figs. 3A and 3B vs
3C), and eventually the symptoms in the new leaves
became similar (arrow in Fig. 3C) to those induced by the
wild-type (WT) virus. This represented a delay of ;1
week with regard to symptom appearance in tobacco
inoculated with the 3 viral RNA transcripts (data not
shown). The appearance of symptoms correlated both
with increases in the levels of viral RNA and with the
detection of RNA 1, not only in upper symptomatic leaves
(Fig. 4, lanes 10 and 11) but also in the inoculated leaves
(Fig. 4, lanes 6 and 8). Virus was not detected in some of
the upper asymptomatic leaves (Fig. 4, lane 9), indicating
that the phenomenon of cycling reported for Fny-CMV in
tobacco (Gal-On et al., 1995) also occurred in these
transgenic plants. There also was some variation in the
accumulation of viral RNA within the inoculated leaf on
different days (Fig. 4, lanes 2 vs 5, 3 vs 6, and 4 vs 7),
probably due to variation in the level of infection in
different parts of the inoculated leaves (see Figs. 3A and
3B). When extracts from the upper leaves showing WT-
like symptoms (analyzed in Fig. 4C, lanes 10 and 11)
were inoculated to nontransformed tobacco, the plants
became infected and showed the presence of all CMV
RNAs (data not presented). To verify that this RNA 1
originated from the transgene, virus was isolated from
these nontransformed tobacco plants, and the 39 end of
the 1a gene was sequenced by the dideoxynucleotide
chain termination method. The sequence of the 1a 39 end
showed the presence of sequences encoding the six
histidines, confirming that the RNA 1 regenerated from
the transgene (data not shown).
Differential susceptibility to CMV in R1- and R2-
generation plants of line B1: Occurrence of atypical
infection symptoms
Because the initial purpose of this work was to study
complementation and not resistance to CMV, seeds
were only obtained from R0-generation plants of lines A1
and B1. A genealogical representation of the different
transgenic lines described in this article is shown in
Figure 5. The R1-generation plants (one for each line),
which were used to obtain seeds for R2-generation
FIG. 2. Detection of viral RNAs in RNA 1 transgenic tobacco plants
inoculated with Fny-CMV transcript RNAs 2 and 3. Northern blot hy-
bridization analysis at 9 d.p.i. of total plant RNA. Samples are from
inoculated leaf of plant line Ro-A1 (lane 1), upper, noninoculated leaf of
plant line R0-A1 (lane 2), inoculated leaf of plant line R0-A3 (lane 3),
upper noninoculated leaf of plant line Ro-A3 (lane 4), noninoculated
tobacco (lane 5), and CMV-infected tobacco (lane 6). All the lanes
contained the same amount of total RNA, although overloading of the
viral RNA in lane 6 led to faster migration.
FIG. 3. Development of systemic infection symptoms in a plant of line R0-A1 inoculated with CMV RNAs 2 and 3. (A and B) Initial chlorotic spots
appeared in a noninoculated leaf at 12 d.p.i. (C) Symptoms increased in severity with time as the leaf expanded (16 d.p.i.). (C, arrow) Presence of
intense symptoms in the small new leaf. Photographs were taken with either incidental light (A and C) or transmitted light (B), the latter of which shows
lesions (B, arrows) not visible under incidental light (A, arrows).
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plants, were not selected by any particular characteristic
other than the presence of the transgene. Thereafter,
three types of experiments were conducted using the R1-
and R2-generation plants to test their susceptibility to
CMV: (1) inoculation with transcript RNAs 2 and 3 and
assessment for symptoms of systemic infection after the
appearance of viral RNA 1, (2) inoculation with purified
Fny-CMV and assessment of symptoms, and (3) inocu-
lation with an extract from tobacco infected with a pseu-
dorecombinant virus derived from Fny-CMV RNAs 1 1 2
and M-CMV RNA 3 (designated F1F2M3-CMV), and as-
sessment of symptoms. Although Fny-CMV RNA 3 and
M-CMV RNA 3 differ only by 1% in nucleotide sequence,
the symptoms induced by the latter are more obvious,
producing bright yellow/white chlorosis (Shintaku et al.,
1992). Thus, the pseudorecombinant virus F1F2M3-CMV
allowed the detection of limited infection foci not visible
after inoculation with Fny-CMV. The results of these
experiments are summarized in Table 1.
Plants of line A1 (R1- and R2-generation; R1-A1 and
R2-A1) were completely susceptible to infection by Fny-
CMV (Fig. 5). The symptoms were WT-like in appearance
with respect to infection in control plants (Table 1 and
Fig. 6A, plant 3 vs plant 5). By contrast, plants of line B1
(R1- and R2-generation; R1-B1 and R2-B1) showed a vari-
ety of symptom responses among plants (Fig. 5) that
could be classified in four categories: WT-like, WT-like
plus necrotic rings, mild chlorosis and necrotic rings,
and no systemic symptoms (Table 1). The necrotic rings
(Fig. 6A, plant 1, and Figs. 6B and 6C) were not observed
on nontransformed plants inoculated with Fny-CMV and
thus represented a unique host response. When R2-
generation plants (Fig. 5) were inoculated with the pseu-
dorecombinant virus F1F2M3-CMV, chlorotic yellow le-
sions appeared in the inoculated leaves of most control
plants as well as R2-A1 plants as early as 4 d.p.i. (as in
plants photographed at 16 d.p.i. and shown in Fig. 7B,
lower leaves). The diameter of the lesions was ;2 mm.
In R2-B1 plants, at 4 d.p.i., the lesions were less apparent
and were ;1 mm in diameter (not shown). By 7 d.p.i., all
except one of the R2-A1 plants became infected system-
ically at the same time as the control plants (see Figs. 7A
and 7B, center vs left plants or leaves). The one excep-
tion showed a delay of 2 days in the onset of symptoms,
which were WT-like but with the addition of necrotic rings
in some leaves (Table 1). By contrast, at 7 d.p.i. only two
R2-B1 plants were showing systemic symptoms, and by
24 d.p.i. and afterward, 7 of 20 R2-B1 plants showed no
systemic symptoms (Table 1), as for plants photographed
at 16 d.p.i. (Figs. 7A and 7B, right vs left and central
plants or leaves). There was considerable variability in
the severity of symptoms among the remaining 13 line B1
plants (Fig. 7C, bottom row) vs nontransformed plants
(Fig. 7C, top left).
Segregation of symptom responses in the R2-
generation of line B1: Identification of two R3-
generation lines with systemic resistance to CMV
The two line R2-B1 plants, which remained asymptom-
atic after inoculation with Fny-CMV virus (50 mg/ml, Table
1), self-pollinated and generated seeds of R3-generation
lines R3-B1A and R3-B1B (Fig. 5). In addition, seeds were
obtained from two of the line R2-B1 plants that remained
asymptomatic after inoculation with F1F3M3-CMV, in a
experiment also described in Table 1, to produce R3-
FIG. 4. Northern blot analysis of viral RNA accumulation at different
d.p.i., after inoculation with viral transcripts of Fny-CMV RNAs 2 and 3
in plant line R0-B4, in (two different) inoculated leaves and systemic
leaves. Total RNAs were extracted from a healthy plant (lane 1); the first
inoculated leaf at 4 (lane 2), 8 (lane 3), and 12 (lane 4) d.p.i.; or the
second inoculated leaf at 4 (lane 5), 8 (lane 6), 12 (lane 7), and 18 (lane
8) d.p.i. or a systemic asymptomatic (lane 9) and two systemic symp-
tomatic leaves (lanes 10 and 11), all at 18 d.p.i. Lanes 9–11 have
one-tenth the RNA loaded in the other lanes.
FIG. 5. Genealogical representation of the different RNA 1-transgenic
tobacco lines described in this report and their respective susceptibility
(S) or resistance (R) to systemic infection by Fny-CMV. (S/R) Some
plants of the line were susceptible, whereas others were systemically
resistant to Fny-CMV. (R*), Systemic resistance to Fny-CMV, although
with different degrees between lines (see text).
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generation lines R3-B1C and R3-B1D (Fig. 5). To test
these plants for resistance, plants from these four lines
were inoculated with extracts from tobacco infected with
F1F2M3-CMV. The results are summarized in Table 2.
All plants from lines R3-B1A and R3-B1B were susceptible
to infection by CMV. However, in contrast to what was seen
in the line R2-B1 plants, the variation in systemic symptoms
among plants was much less. Systemic infection symptoms
were mild, limited to chlorotic flecks in the systemic leaves,
like those shown in Figure 7C leaves P2 and P3. By con-
trast, all plants of line R3-B1C remained asymptomatic in
the systemic leaves (Table 2). In some of the plants of line
R3-B1D, occasional, individual lesions were found in sys-
temic leaves, but the plants otherwise remained asymp-
tomatic (Table 2). In the plants of both lines, R3-B1C and
R3-B1D, yellow, chlorotic lesions developed in the inocu-
lated leaves (as in Fig. 8A).
The resistant lines, R3-B1C and R3-B1D (Fig. 5),
showed complete susceptibility to the pseudorecom-
binant virus L1L2M3-CMV (Table 2), which contains
RNAs 1 and 2 from the subgroup II strain LS-CMV and
RNA 3 of the subgroup I strain M-CMV (Zaitlin et al.,
1994). The symptoms were indistinguishable from
those shown by both the susceptible line R2-A1 plants
and nontransformed tobacco (Fig. 7A and Table 2).
This suggests that the resistance was not effective
against members of CMV subgroup II of CMV, such as
LS-CMV, which show 25% nucleotide sequence diver-
gence from subgroup I strains such as Fny-CMV (Palu-
kaitis et al., 1992).
To test the effect of inoculation with high doses of virus
on the resistance, plants of the most resistant line (R3-
B1C) were inoculated with purified Fny-CMV at a con-
centration of 500 mg/ml. At 37 d.p.i., half of the plants
remained asymptomatic, whereas the other half dis-
played various symptoms, ranging from WT to mild, lo-
calized chlorosis (Table 2). Thus, the resistance could be
overcome in some, but not all the plants, by extremely
high levels of inoculum.
Upper leaves of resistant plants are susceptible to
infection and retain the ability to complement
replication of inoculated viral RNAs 2 and 3
Inoculated plants from resistant line R3-B1C were re-
sistant to systemic infection by F1F2M3-CMV (Table 2).
However, the asymptomatic, noninoculated, upper leaves
of these plants were found to be susceptible to virus
infection if mechanically inoculated with the same virus;
that is, chlorotic lesions developed in these newly inoc-
ulated, upper leaves after inoculation with the pseu-
dorecombinant F1F2M3-CMV, indicating virus cell-to-cell
movement and accumulation (Fig. 8A). However, the
plants retained resistance to systemic infection. Lesions
were similar in size in plants that had (Fig. 8A, right) or
had not (Fig. 8A, left) been inoculated previously with the
same virus in the lower leaves. Moreover, localized flu-
orescence in single epidermal cells was detected after
inoculation of upper leaves of R3-B1C plants with Fny-
CMV RNA 2 transcript plus a modified CMV RNA 3
transcript derived from the construct pL:3a/GFP, in which
the gene encoding the green fluorescent protein (GFP)
was substituted for the viral CP gene (Figs. 8B and 8C).
This indicates that neither resistance nor transgene si-
TABLE 1
Assessment of the Susceptibility of Lines A1 and B1, Plants of the R1- and R2-Generation, to Infection by CMV
Lines Inoculum Infectivitya Pathologyb,c
R1-A1 Fny-CMV RNAs 2 1 3 3/5 3 WT
R2-A1 Fny-CMV RNAs 2 1 3 5/5 5 WT
R1-B1 Fny-CMV RNAs 2 1 3 4/5 2 WT; 1 WT 1 NR; 1 MC 1 NR
R2-B1 Fny-CMV RNAs 2 1 3 5/5 1 WT; 1 WT 1 NR; 3 MC 1 NR
R2-A1 Fny-CMV (10 mg/ml) 9/9 9 WT
R2-B1 Fny-CMV (10 mg/ml) 4/9 3 WT; 1 MC 1 NR
NT tobaccod Fny-CMV (10 mg/ml) 10/10 10 WT
R2-A1 Fny-CMV (50 mg/ml) 9/9 9 WT
R2-B1 Fny-CMV (50 mg/ml) 8/10 5 WT; 3 MC 1 NR
NT tobacco Fny-CMV (50 mg/ml) 10/10 10 WT
R2-A1 F1F2M3-CMV (sap) 18/18 17 WT; 1 WT 1 NR 1 Delay
R2-B1 F1F2M3-CMV (sap) 13/20 4 [P1]; 1 [P2]; 4 [P3]; 4 [P4]
NT tobacco F1F2M3-CMV (sap) 18/18 10 WT
a Number of plants showing symptoms divided by the number of plants inoculated.
b Systemic symptoms induced by Fny-CMV were classified into three categories: WT, wild-type-like; WT 1 NR, wild-type-like symptoms together
with the presence of a varying number of necrotic rings in some of the leaves; MC 1 NR, plants with mild chlorotic symptoms and a varying number
of necrotic rings in some of the leaves.
c Systemic symptoms induced by the pseudorecombinant F1F2M3-CMV were classified on a scale of severity of P1 to P4, shown in Figure 6C,
P1–P4, respectively, to indicate the severity, and extent of systemic yellow chlorosis.
d NT tobacco; nontransformed tobacco.
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lencing had been induced in the upper leaves by the
prior inoculation of a lower leaf.
Resistant plants show a differential reduction in the
accumulation of viral RNA 1 in the inoculated leaf
The analysis of viral RNA accumulation in lesions from
the inoculated leaves of plants from both resistant lines
R3-B1C and R3-B1D showed a dramatic decrease in the
levels of viral RNA 1, ranging from 20-fold less (Figs. 9A
and 9C, lanes 5 and 6) to almost undetectable (Figs. 9A
and 9C, lanes 13 and 14), relative to the levels found in
both susceptible transgenic (R2-A1) and nontransformed
tobacco plants (Figs. 9A and 9C, lanes 1–4 and lanes 11
and 12). This was found in several independent experi-
ments (Fig. 9; data not shown). A proportional, but less
pronounced, 2–13-fold decrease was also observed in
the total levels of viral RNAs 2–4 (Figs. 9A and 9C, lanes
5 and 6 vs lanes 1 and 2 and lanes 13 and 14 vs lane 11,
respectively). The analysis of viral RNA accumulation in
the lesions (shown in Fig. 8A) from inoculated leaves of
plants that had or had not been inoculated previously
with virus in the lower leaves showed the same pattern
of accumulation; that is, less total viral RNA accumulated
in these resistant plants (Figs. 9B and 9D, lanes 2 and 3)
than in nonresistant plants (Figs. 9B and 9D, lane 1). No
trace of viral RNAs was found in leaves above the inoc-
ulated leaves (Fig. 9B, lanes 4–9).
To assess the relative levels with which the 1a protein
expressed from the transgenic mRNA sustained viral
replication (and thus, an indirect measure of the levels of
functional cytoplasmic, transgenic mRNA), total CMV
RNA accumulation levels in the inoculated leaves of
transgenic, susceptible (line R2-A1) and resistant (line
R3-B1C) plants (Fig. 5) inoculated with viral RNAs 2 and
3 were compared with total CMV RNA accumulation after
inoculation with the three viral transcript RNAs (Fig. 10A).
Accumulation of the total Fny-CMV RNAs in plants of
resistant line R3-B1C (Figs. 10A and 10B, lane 1) was
10–12-fold lower than in plants of susceptible line R2-A1
(Figs. 10A and 10B, lanes 3 and 4) when Fny-CMV RNAs
1–3 were used as inoculum, whereas when Fny-CMV
RNAs 2 and 3 were inoculated to plants of line R2-A1, the
levels of total viral RNA accumulation varied from 0.5-fold
(Figs. 10A and 10B, lane 5 vs lane 2) to 2-fold (Figs. 10A
and 10B, lane 7 vs lane 2) to that observed in plants of
line R3-B1C. By contrast, the levels of accumulation of
total viral RNAs were ;8-fold higher when Fny-CMV
RNAs 1–3 were inoculated to plants of the resistant line
FIG. 6. Symptoms induced by Fny-CMV in R1-generation plants. (A) Plants were either noninoculated (plants 2 and 4) or inoculated with Fny-CMV
(plants 1, 3, and 5). Plants were from line B1 (plants 1 and 2), line A1 (plants 3 and 4), or nontransformed tobacco (plant 5). Note the presence of
necrotic rings in the infected B1 plant (arrow), magnified in B and C. (B) Lesion under transmitted light. (C) Same lesion viewed using an FITC/TRITC
epifluorescent filter, which highlights (in orange) the necrotized areas. (Bar) 1 mm.
FIG. 7. Symptoms induced in transgenic and nontransformed plants at 16 d.p.i. with sap from tobacco infected with the pseudorecombinant virus
F1F2M3-CMV. (A and B) Nontransformed tobacco (left), a plant of line R2-A1 (center), and a resistant plant of line R2-B1 (right). Shown are the entire
plants (A) and detached, systemic (upper row) and inoculated (lower row) leaves of the same plants (B). (C) Variability of symptoms induced in different
plants of line R2-B1. (Lower row, left to right) Responses designated by severity as less severe than WT (P1), large chlorotic flecks on and adjacent
to the main veins (P2), multiple, small chlorotic flecks associated with main veins (P3), one or two small chlorotic flecks on a vein (P4), or no symptoms
(P5). (Upper row) Infected (left) and healthy (right) nontransformed tobacco leaves.
FIG. 8. Susceptibility of line R3-B1C to virus replication in the inoculated leaves. (A) Symptoms induced in the inoculated leaf of two plants of line
R3-B1C, at 20 d.p.i. with sap from tobacco infected with the pseudorecombinant virus F1F2M3-CMV. One of the plants (right leaf) had been inoculated
22 days previously to the above inoculation on a lower leaf with the same virus. The other plant (left leaf) had not previously been inoculated. (B and
C) GFP fluorescence at 4 d.p.i. in epidermal cells (arrows) of two plants from line R3-B1C inoculated with transcript Fny-CMV RNA 2 plus transcript
RNA 3 derived from construct pL:3a/GFP with the CP gene replaced by the GFP gene. The plants had been either noninoculated previously (B) or
inoculated 16 days before (C) on a lower leaf with Fny-CMV. F1F2L:3a/GFP yields infections limited to single cells (arrows) in the absence of the CP.
(Bars) 100 mm.
TABLE 2
Assessment of the Susceptibility of Lines R3-A–D
to Infection by CMV
Lines Inoculum Infectivitya Pathologyb,c
NT tobaccod F1F2M3-CMV (sap) 20/20 20 WT
R3-B1A F1F2M3-CMV (sap) 20/20 20 [P2; P3]
NT tobacco F1F2M3-CMV (sap) 20/20 20 WT
R3-B1B F1F2M3-CMV (sap) 20/20 20 [P2; P3]
NT tobacco F1F2M3-CMV (sap) 20/20 20 WT
R3-B1C F1F2M3-CMV (sap) 0/20
NT tobacco F1F2M3-CMV (sap) 16/16 20 WT
R3-B1D F1F2M3-CMV (sap) 10
e/18 [P4; P5]
NT tobacco L1L2M3-CMV (sap) 20/20 20 WT
R2-A1 L1L2M3-CMV (sap) 20/20 20 WT
R3-B1C L1L2M3-CMV (sap) 20/20 20 WT
R3-B1D L1L2M3-CMV (sap) 20/20 20 WT
NT tobacco Fny-CMV (500 mg/ml) 5/5 5 WT
R3-B1C Fny-CMV (500 mg/ml) 8/16 4 WT; 4 MC
a Number of plants showing symptoms divided by the number of
plants inoculated.
b Systemic symptoms induced by Fny-CMV were classified as WT,
wild-type-like, and MC, localized mild chlorosis in systemic leaves
without leaf deformation.
c Systemic symptoms induced by the pseudorecombinant F1F2M3-
CMV were classified on a scale of severity of from P1 to P5, shown in
Figure 6C, P1–P5, respectively, to indicate the severity and extent of
systemic yellow chlorosis.
d NT tobacco, nontransformed tobacco.
e In these 10 plants, only occasional isolated yellow flecks were
detected in some systemic leaves, similar to P4 (Fig. 6C, P4).
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FIG. 9. Northern blot hybridization analysis of the viral RNA accumulation in the lesions of leaves inoculated with sap from tobacco infected with
the pseudorecombinant virus F1F2M3-CMV. (A) Experiment 1: total RNAs were extracted at 9 d.p.i. from two nontransformed tobacco (lanes l and 2),
two plants of line R2-A1 (lanes 3 and 4), and two plants of line R3-B1C (lanes 5 and 6). Experiment 2: total RNAs were extracted at 10 d.p.i. from
nontransformed tobacco (lane 11), a plant of line R2-A1 (lane 12), a plant of line R3-B1C (lane 13), and a plant of line R3-B1D (lane 14). (Lanes 7–10)
Total RNA from noninoculated plants: nontransformed tobacco (lane 7), plant line R2-A1 (lane 8), plant line R3-B1C (lane 9), and plant line R3-B1D (lane
10). (B) Total RNAs were extracted at 20 d.p.i. from a plant line R2-A1 (lane 1), and the two plants of line R3-B1C (lanes 2 and 3) shown in Figure 8A.
Before this inoculation, one of these plants (lane 3) had been inoculated on a lower leaf 22 days before with the same virus (corresponds to Fig. 8A,
right); the other plant (lane 2) had not been inoculated previously (corresponds to Fig. 8A, left). Total RNA was analyzed from the three consecutive
leaves above the inoculated leaf represented in lane 2 (lanes 4–6) or from the three consecutive leaves above the inoculated leaf represented in lane
3 (lanes 7–9). (C and D) The Cerenkov c.p.m. (3 1023) for the viral RNAs in the corresponding lanes are shown in the graphs and charts. CMV RNAs
are indicated on the left of A and B in descending order. (RNA 3 def.p) Spontaneously appearing defective form of viral RNA 3 with a deletion of 411
nucleotides in the 3a gene.
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R3-B1C than when the inoculum was Fny-CMV RNAs 2
and 3 (Figs. 10A and 10B, lane 1 vs lane 2; lane 2
contains 10 times more RNA loaded than lane 1). Thus,
RNA 1 derived from the inoculum was still supporting
replication and was not completely suppressed. The
accumulation of total Fny-CMV RNAs was much less in
plants of susceptible line R2-A1 inoculated with Fny-CMV
RNAs 2 and 3 than in those inoculated with Fny-CMV
RNAs 1–3, varying from 40-fold (Figs. 10A and 10B, lane
7 vs lanes 3 and 4) to 230-fold (Figs. 10A and 10B, lane 5
vs lanes 3 and 4). Therefore, it appears that the resistant
line R3-B1C was able to suppress Fny-CMV RNA accu-
mulation 10–12-fold relative to the susceptible line R2-A1
but did not show much difference in its ability to support
viral RNA accumulation after inoculation with Fny-CMV
RNAs 2 and 3 compared with the susceptible line R2-A1.
This indicates that the level of 1a protein probably was
similar in the two transgenic lines. The apparent cross-
hybridization to the ribosomal RNAs in Fig. 10 (and, to a
lesser extent, in Figs. 2, 4, and 9) is a hybridization
artifact caused by partial degradation of the genomic
RNAs [described by Dougherty (1983) and Palukaitis et
al. (1983)]. This extent of degradation does not appear to
be related to the resistance.
DISCUSSION
We obtained transgenic tobacco plants that express
biologically active 1a protein, able to complement the
replication of viral RNAs 2 and 3 in the absence of viral
RNA 1. Initially, the plants remained asymptomatic and
the transgenic mRNA was undetectable by Northern blot
analysis. However, RNAs 2–4 were readily detected in
the same assay, not only in inoculated leaves but also in
some systemic leaves. This suggests that the transgene
not only complemented the replication of the heterolo-
gous viral RNAs but also allowed long-distance move-
ment in the plant. On the other hand, it also indicates that
the transgenic mRNA was not used efficiently as a tem-
plate by the viral RNA-dependent RNA polymerase
(RdRp), probably because the transgenic mRNA had ad-
ditional nonviral sequences at both 59 and 39 ends.
However, after a period of time, viral RNA 1 regenerated
from the transgenic mRNA. This regeneration coincided
with the appearance of RNA 1, an increase in the accu-
mulation of the other viral RNAs, and the appearance of
a WT viral phenotype in susceptible plants. Although we
have not investigated the regeneration mechanism, it
could have taken place by internal initiation of the viral
RdRp on the transgenic mRNA, by use of partially de-
graded transgenic mRNA as a template by the viral
RdRp, or by recombination during replication, between
the common 39 NCRs of RNAs 2, 3, or 4 and similar
sequences in the transgenic mRNA.
Even though all the R0-generation transgenic plants
were susceptible to the virus, it was possible to obtain
two R3-generation lines (B1C and B1D) with systemic
resistance to Fny-CMV, and another two lines (B1A and
B1B) with attenuated systemic symptoms, through the
selection of plants that showed differential susceptibility
FIG. 10. Northern blot hybridization analysis of the viral RNA accu-
mulation in transgenic tobacco leaves inoculated with Fny-CMV tran-
script RNAs. (A) At 5 d.p.i., total RNA was extracted from two plants of
line R3-B1C (lanes 1 and 2) and four R2-generation plants of line A1
(lanes 3–8). The plants were inoculated either with Fny-CMV transcript
RNAs 1 1 2 and 3 (lanes 1, 3, and 4) or RNAs 2 and 3 alone (lanes 2,
5–8). Lanes 2, 5, and 7 contain 10 times the RNA loaded in the
remaining lanes. (B) The Cerenkov c.p.m. for the viral RNAs from the
samples analyzed in the corresponding lanes are shown in the graph
and in the chart. The c.p.m. in lanes 2, 5, and 7 have been normalized
to the c.p.m. expected for 10-fold less RNA.
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to the virus in the R1- and R2-generations of line B1 (Fig.
5). The necrotic rings (see Fig. 6) observed in inoculated
and systemic leaves of some plants of lines R3-B1A,
R3-B1B, and R3-B1D, but not in R3-B1C (not shown), did
not correlate with the establishment of resistance but
appear to relate to a hypersensitive response that does
not confine infection and may have some subtle effects
on the infection process.
Plants exhibiting systemic resistance to CMV still
showed virus replication and cell-to-cell movement in
the inoculated leaves of these plants, as seen in
Figures 8 and 9 for line R3-B1C. However, the analysis
of viral RNAs showed a drastic reduction in the levels
of accumulation of viral RNA 1 (Fig. 9), compared with
viral RNA accumulation in both susceptible transgenic
and nontransformed plants. There was a proportional,
but less pronounced, decrease in the levels of accu-
mulation of the remaining viral RNAs. Hence, the level
of 1a protein must have fallen below some threshold
before the accumulation of the other viral RNAs was
affected. Once this threshold was reached, the rate of
replication and accumulation of the remaining viral
RNAs, as well as the accumulation of their gene prod-
ucts, decreased. Relative to CMV infection in nonre-
sistant plants, the accumulation levels would show
further reductions in newly invaded cells.
There seems to be a specific mechanism that differ-
entially and incompletely reduces viral RNA 1 accumu-
lation in the inoculated leaf of resistant plants. One
possibility is that the phenomenon of incomplete cosup-
pression (Lindbo et al., 1993) was active in these plants,
and after inoculation with viral RNA, the levels of viral
RNA 1 would be affected by this cosuppression. How-
ever, after inoculation with viral RNAs 2 and 3, these
plants sustained levels of accumulation of viral RNA
comparable to those in transgenic, susceptible plants
(Fig. 10). This indicates that the initial levels of transgenic
1a protein in the resistant line were not lower than those
in the susceptible line.
Another possible mechanism for resistance engen-
dered by CMV RNA 1 is that the inoculation with viral
RNA triggered a mechanism of degradation that would
cosuppress both transgenic mRNA and viral RNA 1 after
a threshold level was reached (Lindbo et al., 1993). The
fact that this resistance did not operate against the
pseudorecombinant L1L2M3-CMV suggests that the re-
duction in the levels of viral RNA 1 may be due to a
homology-dependent effect. This is similar in some re-
spects to resistance induced by a defective polymerase
gene (Zaitlin et al., 1994) but different from resistance
induced by the expression of a CMV replicon in trans-
genic tobacco (Suzuki et al., 1996). In the latter case,
resistance was also effective against the distantly re-
lated tomato aspermy cucumovirus, which is not consis-
tent with a homology-dependent gene-silencing mecha-
nism. The limitation of the resistance engendered by the
CMV replicon to low levels of inoculum (Suzuki et al.,
1996) also stands in contrast to the resistance observed
against high levels of inoculum by transgenic plants
expressing either the defective polymerase gene (Ander-
son et al., 1992) or RNA 1 of CMV (present report).
Although it is not clear whether similar mechanisms
might be operating in the latter two situations, the incom-
plete inhibition of virus replication and the effect on
systemic movement are other features common to both
of these examples of resistance to CMV.
Remarkably, the resistant plants were able to comple-
ment the replication of viral RNAs 2 and 3 in upper leaves
after reinoculation. Furthermore, these upper leaves
were also susceptible to virus infection (Fig. 8). This
shows that in the resistant plants, silencing of the trans-
gene was not being induced systemically by the initial
inoculation. Thus, despite the presence of virus replica-
tion and cell-to-cell movement in the inoculated leaf of
resistant plants, this resistance cannot be considered a
recovery phenotype in which an extreme systemic resis-
tance is established, as has been described for other
viral systems (Lindbo et al., 1993; Guo and Garcia, 1997;
Tanzer et al., 1997). This latter response may involve the
elicitation of some signal in the initially inoculated leaf
that spreads through the plants, generating a systemic
silencing (Palauqui et al., 1997; Voinnet and Baulcombe,
1997; Jorgensen et al., 1998). It is possible that the pro-
posed suppression observed here is localized to the
actual virus-infected tissue and that it does not affect
noninfected tissue or that it is confined to the inoculated
leaf. Alternatively, a signal from the inoculated tissue
could be delivered that triggers an inefficient systemic
silencing that does not silence the transgenic mRNA.
This might be because the transgene mRNA concentra-
tion was too low (Jorgensen et al., 1998), and thus the
inhibitory effect in upper leaves after reinoculation would
be barely discernible from suppression observed in a
leaf of a plant inoculated de novo.
On the other hand, the presence of transgenic 1a
protein in the systemic tissue of resistant plants after
prior inoculation with virus requires the existence of a
resistance mechanism other than the silencing of the
viral RNA 1. This mechanism is needed to explain the
lack of systemic infection in these plants inoculated with
viral RNAs 2 and 3, against which there seems to be no
targeted silencing. In the inoculated leaves of resistant
and susceptible plants, RNAs 2 and 3 accumulated to
comparable levels (Fig. 10A, lane 2 vs lanes 5 and 8) and
systemic infection did not occur in resistant plants,
whereas it did in susceptible plants (Fig. 4). Thus, there
must be some mechanism inhibiting systemic infection.
The nature of this mechanism and its relationship to the
mechanism of inhibition of RNA 1 accumulation may or
may not be related.
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MATERIALS AND METHODS
Plants, viruses, and inoculation of plants.
Tobacco plants (Nicotiana tabacum cv. Turkish Sam-
sun NN) were used for plant transformation and as
susceptible plants in resistance tests. Plants were grown
in the greenhouse or in a growth chamber at 25°C. CMV
strain Fny (Roossinck and Palukaitis, 1990) was purified
from infected tobacco as described (Palukaitis et al.,
1992). The pseudorecombinant virus made from Fny-
CMV RNAs 1 and 2 and M-CMV RNA 3 and the pseu-
dorecombinant virus made from LS-CMV RNAs 1 and 2
and M-CMV RNA 3 were obtained by mixing, respec-
tively, Fny-CMV transcript RNAs 1 and 2 for the former
combination and LS-CMV transcript RNAs 1 and 2 for the
latter combination with M-CMV transcript RNA 3, derived
from the corresponding full-length cDNA clones (Rizzo
and Palukaitis, 1990; Zhang et al., 1994; Shintaku and
Palukaitis, 1990) to generate virus F1F2M3-CMV and
virus L1L2M3-CMV. Plants were inoculated mechanically
with purified virus, virus infected leaf extract (diluted 1:10
in 50 mM sodium phosphate, pH 7), or transcript RNAs
by gently rubbing the inocula onto aluminum oxide-
dusted leaves. Because particles of F1F2M3-CMV and
L1L2M3-CMV do not store well after isolation, sap from
infected plants, inoculated 10–12 days earlier, was used
as the source of inoculum.
Generation of the plant expression construct and
plant transformation
To generate plants expressing biologically active 1a
protein, the cDNA sequence corresponding to the RNA 1
of Fny-CMV was inserted into the plant transformation
vector pROK2 as shown in Figure 1. A DNA fragment
corresponding to a full-length, biologically active, cDNA
clone of Fny-CMV RNA 1 (pF109 C-His), modified by the
addition of a hexahistidine-coding sequence at the 39
end of the 1a gene and known not to adversely affect
viral replication (unpublished observation), was ampli-
fied by the PCR. The primers contained restriction endo-
nuclease sites at their 59 ends, to facilitate cloning into
the plant expression vector pROK2 digested with the
same enzymes (BamHI and SacI). Besides the 1a gene,
the insert contained the viral RNA 1 59 and 39 NCRs and
a nucleotide sequence corresponding to the T7 promoter
upstream the viral sequence (Fig. 1). After ligation into
pROK2, the plasmid was electroporated into Agrobacte-
rium tumefaciens strain LBA-4404, which was used to
transform tobacco using the leaf disc method (Horsch et
al., 1985), with plants regenerating from calli in a kana-
mycin-selective medium.
Nucleic acid extraction and analysis
Leaves analyzed in Figures 2 and 4 were sampled by
taking a single leaf disk per plant (;50 mg), whereas
leaves analyzed in Figures 9 and 10 were sampled by
taking 10 smaller leaf disks per plant (;50 mg). In inoc-
ulated leaves of Figure 9, the leaf disks corresponded to
lesions. Total RNAs were extracted from plant tissues by
grinding them in 300 ml of 50 mM Tris–HCl, pH 8.0, 10
mM EDTA, 2% SDS, and 0.5% 2-mercaptoethanol. The
samples were extracted with phenol, and RNA was pre-
cipitated with ethanol as described previously (Palukaitis
et al., 1985). For Northern blot analysis, RNA samples
were recovered by centrifugation, fractionated by elec-
trophoresis in 1.5% agarose gels under denaturing con-
ditions (6% formaldehyde), blotted to nitrocellulose mem-
branes, and hybridized to [32P] RNA probes complemen-
tary to the 39 NCR of each Fny-CMV RNA (Gal-On et al.,
1994). The blots were washed and autoradiographed as
described by Sambrook et al. (1989). After the blot anal-
ysis, to quantify the relative amounts of viral RNA, the
areas of the nitrocellulose membranes at where each
viral RNA had transferred were isolated, and the corre-
sponding Cerenkov c.p.m. were obtained in a liquid scin-
tillation counter.
Detection of biologically active transgene product
Direct detection of transgenic 1a protein in plant tissue
was attempted by Western blotting. Proteins were sepa-
rated by SDS–PAGE, blotted to nitrocellulose (Towbin et
al., 1979), and probed with a polyclonal antiserum against
the 1a protein as described (Gal-On et al., 1994). An
indirect approach to confirm the expression of 1a protein
was by detection of the products of the 1a proteins,
biological activity; that is, plants were inoculated with
CMV RNA transcripts 2 and 3 as described above, and
replication of the inoculated RNAs was detected by three
methods: (1) RT-PCR amplification of viral sequences
using primers specific for RNA 2 (corresponding to nu-
cleotides 1533–1549 and 2646–2660) or RNA 3 (corre-
sponding to nucleotides 110–134 and 944–958), (2) de-
tection of viral RNAs in plant tissue by Northern blot
hybridization, as indicated above, or (3) with a modified
RNA 3 transcript derived from construct pL:3a/GFP, in
which the gene encoding the GFP was substituted for
the viral CP gene, and with detection of GFP-derived
fluorescence by confocal laser scanning microscopy as
described previously (Canto et al., 1997).
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